400 related articles for article (PubMed ID: 23827125)
1. Lower n-3 long-chain polyunsaturated fatty acid values in patients with phenylketonuria: a systematic review and meta-analysis.
Lohner S; Fekete K; Decsi T
Nutr Res; 2013 Jul; 33(7):513-20. PubMed ID: 23827125
[TBL] [Abstract][Full Text] [Related]
2. Dietary long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria: a randomized controlled trial.
Koletzko B; Sauerwald T; Demmelmair H; Herzog M; von Schenck U; Böhles H; Wendel U; Seidel J
J Inherit Metab Dis; 2007 Jun; 30(3):326-32. PubMed ID: 17431817
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.
Mazahery H; Stonehouse W; Delshad M; Kruger MC; Conlon CA; Beck KL; von Hurst PR
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218722
[TBL] [Abstract][Full Text] [Related]
4. Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review.
Fekete K; Marosvölgyi T; Jakobik V; Decsi T
Am J Clin Nutr; 2009 Jun; 89(6):2070S-2084S. PubMed ID: 19420097
[TBL] [Abstract][Full Text] [Related]
5. Does dietary DHA improve neural function in children? Observations in phenylketonuria.
Koletzko B; Beblo S; Demmelmair H; Müller-Felber W; Hanebutt FL
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):159-64. PubMed ID: 19615874
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid in red blood cells of term infants receiving two levels of long-chain polyunsaturated fatty acids.
Hoffman DR; Wheaton DK; James KJ; Tuazon M; Diersen-Schade DA; Harris CL; Stolz S; Berseth CL
J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):287-92. PubMed ID: 16540798
[TBL] [Abstract][Full Text] [Related]
7. Effects of LC-PUFA Supplementation in Patients with Phenylketonuria: A Systematic Review of Controlled Trials.
Couce ML; de Castro MJ; de Lamas C; Leis R
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284588
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.
Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525
[TBL] [Abstract][Full Text] [Related]
9. Biochemical effects of supplemented long-chain polyunsaturated fatty acids in hyperphenylalaninemia.
Agostoni C; Scaglioni S; Bonvissuto M; Bruzzese MG; Giovannini M; Riva E
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):111-5. PubMed ID: 11237478
[TBL] [Abstract][Full Text] [Related]
10. Long-chain polyunsaturated fatty acid status in phenylketonuric patients treated with tetrahydrobiopterin.
Vilaseca MA; Lambruschini N; Gómez-López L; Gutiérrez A; Moreno J; Tondo M; Artuch R; Campistol J
Clin Biochem; 2010 Mar; 43(4-5):411-5. PubMed ID: 19948162
[TBL] [Abstract][Full Text] [Related]
11. Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet.
Moseley K; Koch R; Moser AB
J Inherit Metab Dis; 2002 Feb; 25(1):56-64. PubMed ID: 11999981
[TBL] [Abstract][Full Text] [Related]
12. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
13. Effect of different levels of docosahexaenoic acid supply on fatty acid status and linoleic and α-linolenic acid conversion in preterm infants.
Sauerwald UC; Fink MM; Demmelmair H; Schoenaich PV; Rauh-Pfeiffer AA; Koletzko B
J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):353-63. PubMed ID: 22008957
[TBL] [Abstract][Full Text] [Related]
14. [Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients].
Gutiérrez-Mata AP; Vilaseca MA; Capdevila-Cirera A; Vidal-Oller M; Alonso-Colmenero I; Colomé R; López-Sala A; Lambruschini-Ferri N; Gutiérrez A; Gassió R; Artuch R; Campistol J
Rev Neurol; 2012 Aug; 55(4):200-6. PubMed ID: 22829083
[TBL] [Abstract][Full Text] [Related]
15. Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats.
Tu WC; Mühlhäusler BS; Yelland LN; Gibson RA
Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):53-60. PubMed ID: 22521090
[TBL] [Abstract][Full Text] [Related]
16. Long-chain polyunsaturated fatty acid status in children, adolescents and adults with phenylketonuria.
Gramer G; Haege G; Langhans CD; Schuhmann V; Burgard P; Hoffmann GF
Prostaglandins Leukot Essent Fatty Acids; 2016 Jun; 109():52-7. PubMed ID: 27269713
[TBL] [Abstract][Full Text] [Related]
17. Supplementation with a powdered blend of PUFAs normalizes DHA and AA levels in patients with PKU.
Jans JJ; de Sain-van der Velden MG; van Hasselt PM; van den Hurk DT; Vaz FM; Visser G; Verhoeven-Duif NM
Mol Genet Metab; 2013 Jun; 109(2):121-4. PubMed ID: 23562298
[TBL] [Abstract][Full Text] [Related]
18. Polyunsaturated fatty acid (PUFA) changes in serum and liver of undernourished rats given dietary vitamin B6 supplementation.
Bertrandt J; Klos A; Debski B
J Nutr Sci Vitaminol (Tokyo); 2005 Jun; 51(3):129-34. PubMed ID: 16161761
[TBL] [Abstract][Full Text] [Related]
19. Intake of arachidonic acid-containing lipids in adult humans: dietary surveys and clinical trials.
Kawashima H
Lipids Health Dis; 2019 Apr; 18(1):101. PubMed ID: 30992005
[TBL] [Abstract][Full Text] [Related]
20. Effect of supplementation of arachidonic acid (AA) or a combination of AA plus docosahexaenoic acid on breastmilk fatty acid composition.
Smit EN; Koopmann M; Boersma ER; Muskiet FA
Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):335-40. PubMed ID: 10913225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
